Inbios Reagents
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice indicating its intent to award a sole source firm fixed-price purchase order to InBios International, Inc. for the InBios DENV Detect TM IgM Capture Elisa Kit. This action is for supplies critical to the CDC's ongoing DENV surveillance program. Responses to this notice are due by March 27, 2026, 5pm EST.
Scope of Requirement
The CDC requires the InBios DENV Detect TM IgM Capture Elisa Kit for its Dengue Branch Diagnostic Laboratory. This specific kit is highlighted as the only serology test approved by the FDA for dengue diagnosis, making it essential for the agency's DENV surveillance program.
Contract & Timeline
- Type: Firm Fixed-Price Purchase Order (Intent to Award)
- Authority: FAR 6.103-1 (SAP) - Sole Source
- Set-Aside: None (Sole Source)
- Response Due: March 27, 2026, 5pm EST
- Published: March 23, 2026
Additional Notes
This notice is an intent to award a sole source contract and is not a request for competitive quotations. However, any quotations or responses received within 15 days of issuance will be considered by the government. The decision to not compete this proposed contract, based on responses, remains solely at the government's discretion. Information submitted will primarily be used to determine the feasibility of a competitive procurement. Responses should be emailed to the contract specialist.